Vascular Diseases: Clinical Trials

23867 completed, 8163 unknown, 5492 recruiting, 2863 terminated. 16839 Not applicable, 5701 Phase 2, 4114 Phase 3, 3670 Phase 4, 3367 Phase 1.

By phase and status

Phase	Trials	Status
Not applicable	16839	Completed 8432, Unknown 2996, Recruiting 2288, Not yet recruiting 1012, Terminated 853, Active not recruiting 603, Withdrawn 447, Enrolling by invitation 137, Suspended 71
Phase 2	5701	Completed 3064, Unknown 712, Terminated 693, Recruiting 508, Withdrawn 266, Active not recruiting 245, Not yet recruiting 173, Suspended 22, Enrolling by invitation 18
Phase 3	4114	Completed 2440, Unknown 546, Terminated 391, Recruiting 340, Not yet recruiting 136, Active not recruiting 135, Withdrawn 105, Enrolling by invitation 13, Suspended 8
Phase 4	3670	Completed 2037, Unknown 763, Terminated 292, Recruiting 264, Not yet recruiting 123, Withdrawn 121, Active not recruiting 47, Enrolling by invitation 17, Suspended 6
Phase 1	3367	Completed 1887, Unknown 394, Terminated 381, Recruiting 300, Withdrawn 142, Active not recruiting 127, Not yet recruiting 111, Suspended 19, Enrolling by invitation 6
Early Phase 1	433	Completed 153, Unknown 85, Recruiting 80, Terminated 37, Not yet recruiting 36, Withdrawn 21, Active not recruiting 10, Enrolling by invitation 7, Suspended 4

Follow Vascular Diseases: new trials by email Literature Review of Vascular Diseases trials Research Report on Vascular Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance Vigabatrin Pill, Placebo oral tablet - Hyperinsulinism, Insulin Resistance	Phase 2	Withdrawn	University of Arizona		2030-04-15	2025-07-30
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease FGF-1, Placebo - Peripheral Arterial Disease, Stenosis	Phase 1 / Phase 2	Not yet recruiting	Venturis Therapeutics, Inc.	24	2028-10-15	2026-08-19
The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage Vectris trial leads and stimulation, Sham - Vasospasm, Cerebral, Aneurysmal Subarachnoid Hemorrhage	Not applicable	Suspended	University of Alabama at Birmingham	25	2028-07-31	2026-09-24
Effect of Ginger on Heavy Menstrual Bleeding in Women With Coagulation Disorders Ginger, Placebo - Women With Coagulation Disorders	Early Phase 1	Not yet recruiting	University of Valladolid	74	2028-02-01	2026-05-19
MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma Oncology-Embedded Cardiovascular Risk Assessment Pathway, Primary Care Provider-Directed Cardiovascular Risk Assessment Pathway - Multiple Myeloma, Heart Disease Risk Factors	Not applicable	Not yet recruiting	University of Vermont Medical Center	33	2028-02-01	2026-08-25
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection Ulinastatin and Thymalfasin, Ulinastatin - Aortic Aneurysm and Dissection	Not applicable	Not yet recruiting	Nanjing Medical University	300	2027-12-31	2026-02-02
Essential Acute Stroke Care in Low Resource Settings: a Pilot studY Acute stroke care Intervention arm - Acute Stroke	Not applicable	Not yet recruiting	The George Institute	300	2027-12-30	2026-06-11
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion Vitamin B6 25 MG, Vitamin B6 50 MG, Vitamin B6 100 MG - Ischemia Reperfusion Injury, Peripheral Artery Disease	Early Phase 1	Not yet recruiting	Milton S. Hershey Medical Center	30	2027-12-01	2026-03-17
Needle Free Assessment of Myocardial Oxygenation in Healthy Subjects RespirAct - Coronary Artery Disease	Not applicable	Not yet recruiting	Indiana University	80	2027-11-01	2026-10-26
REstoring Flow by REvascularization With Submaximal Angioplasty in Hemodynamic IntraCranial Atherosclerotic Stenosis Submaximal balloon angioplasty - Intracranial Atherosclerotic Disease, Stroke	Not applicable	Not yet recruiting	Case Western Reserve University	159	2027-10-01	2025-11-04
Veteran Centered Meal Intervention in Chronic Kidney Disease Medically tailored meals (MTMs) - Chronic Kidney Disease	Not applicable	Not yet recruiting	VA Office of Research and Development	100	2027-10-01	2026-09-03
Safety And Field Evaluation of Plasma Lyophilized for Acute and Surgical Management Applications Freeze-Dried Plasma, Conventional Plasma - Thromboembolic Event, FDP	Phase 4	Not yet recruiting	Teleflex	867	2027-10-01	2026-09-30
The Feasibility and Effects of Exercise on Patients Suffering From Multiple Myeloma Individual Exercise, Group Exercise - Multiple Myeloma	Not applicable	Suspended	Medical University of Vienna	45	2027-09-01	2026-10-09
COOLing of the Ischemic PENumbra in Patients With Acute Ischemic Stroke. PEN-Cool Conductive Head-and-Neck Cooling System, Standard Reperfusion Therapy / Routine Care - Acute Ischemic Stroke	Not applicable	Not yet recruiting	Christian Medical College and Hospital, Ludhiana, India	55	2027-09-01	2026-09-28
Mobile Health Management of Hypertension mHealth Coaching Intervention, Enhanced Usual Care - Hypertension	Not applicable	Not yet recruiting	University of Chicago	40	2027-09-01	2026-08-10
Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141) - low dose, Human Recombinant Fibroblast Growth Factor-1 (FGF1-141) - high dose, Placebo - Coronary Disease, Coronary Heart Disease	Phase 2	Not yet recruiting	Venturis Therapeutics, Inc.	150	2027-09-01	2026-08-19
Glial Fibrillary Acidic Protein Testing and Handheld Near Infrared Spectroscopy Technology CEREBO in India. GFAP/D-Dimer Point-of-Care Testing & CEREBO Near-Infrared Spectroscopy (NIRS), CT Head - Stroke	Not applicable	Not yet recruiting	Christian Medical College and Hospital, Ludhiana, India	232	2027-09-01	2026-09-28
A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE) Rivaroxaban (Xarelto, BAY59-7939), Standard of care (SOC) - Venous Thromboembolism, Children Under 2 Years		Not yet recruiting	Bayer	850	2027-09-01	2026-10-02
Stroke Rehabilitation Using Extended Reality. RehAtt XR System - Stroke	Not applicable	Not yet recruiting	Värmland County Council, Sweden	9	2027-09-01	2026-09-10
Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients With Septic Coagulopathy • Sivelestat intravenous infusion, NaCl intravenous infusion - Septic Shock, Coagulopathy	Phase 2	Not yet recruiting	University Hospital, Strasbourg, France	120	2027-08-01	2026-08-20

Showing 20 of 46038. Sign in to see all of them.

Narrower conditions

Stroke (7803)  ·  Hypertension (5920)  ·  Coronary Artery Disease (4734)  ·  Multiple Myeloma (3661)  ·  Ischemic Stroke (2553)  ·  Cardiovascular Diseases (2163)  ·  Myocardial Infarction (1962)  ·  Diabetes Mellitus (1560)  ·  Coronary Disease (1498)  ·  Atherosclerosis (1482)  ·  Acute Coronary Syndrome (1461)  ·  Peripheral Arterial Disease (1358)  ·  Myocardial Ischemia (1094)  ·  Diabetic Foot (1031)  ·  Hypertension, Pulmonary (1012)

Broader conditions

Cardiovascular Diseases (43875)  ·  Pathological Conditions, Signs and Symptoms (14552)  ·  Nervous System Diseases (14075)  ·  Central Nervous System Diseases (13114)  ·  Brain Diseases (13011)  ·  Cerebrovascular Disorders (12392)  ·  Heart Diseases (11208)  ·  Pathologic Processes (10250)  ·  Myocardial Ischemia (9326)  ·  Arterial Occlusive Diseases (8047)  ·  Arteriosclerosis (7563)  ·  Immune System Diseases (5384)  ·  Hemic and Lymphatic Diseases (5238)  ·  Signs and Symptoms (5204)

Interventions

Dexamethasone (900)  ·  Aspirin (546)  ·  Clopidogrel (515)  ·  Bortezomib (483)  ·  Lenalidomide (461)  ·  Cyclophosphamide (416)  ·  Standard of Care (374)  ·  Exercise (365)  ·  Amlodipine (361)  ·  Rivaroxaban (307)  ·  Ticagrelor (291)  ·  Atorvastatin (284)  ·  Calcium Dobesilate (280)  ·  Blood Specimen Collection (279)  ·  Percutaneous Coronary Intervention (269)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (475)  ·  Assistance Publique - Hôpitaux de Paris (333)  ·  Assiut University (322)  ·  Mayo Clinic (283)  ·  Riphah International University (221)  ·  Bayer (217)  ·  Boehringer Ingelheim (208)  ·  Novartis Pharmaceuticals (206)  ·  National Taiwan University Hospital (200)  ·  Brigham and Women's Hospital (194)  ·  National Cancer Institute (NCI) (193)  ·  Beijing Tiantan Hospital (191)  ·  VA Office of Research and Development (190)  ·  AstraZeneca (181)  ·  Yonsei University (177)

Countries

United States (13399)  ·  China (4731)  ·  France (3503)  ·  Germany (2891)  ·  Canada (2623)  ·  United Kingdom (2539)  ·  Italy (2480)  ·  Spain (2014)  ·  South Korea (1895)  ·  Netherlands (1549)  ·  Turkey (Türkiye) (1421)  ·  Belgium (1289)  ·  Switzerland (1238)  ·  Denmark (1233)  ·  Brazil (1121)

Results publications

PMID 33175411, PMID 34813082, PMID 42573020, PMID 35224730, PMID 37870112, PMID 36326435, PMID 36398903, PMID 31867054, PMID 32905623, PMID 35244208, PMID 36645250, PMID 32499241, PMID 34184251, PMID 34196963, PMID 38682786, PMID 33337539, PMID 33779986, PMID 35857365, PMID 36700520, PMID 39968829, PMID 41114449, PMID 18190818, PMID 33502773, PMID 33769555, PMID 34932836, PMID 40875095, PMID 42035974, PMID 19717846, PMID 34022170, PMID 34487721, PMID 37059239, PMID 37330702, PMID 37565307, PMID 39963789, PMID 16731270, PMID 21899409, PMID 33089502, PMID 33357481, PMID 34515113, PMID 38989575, PMID 39526682, PMID 2375765, PMID 25671797, PMID 25940520, PMID 26898852, PMID 28886621, PMID 30957581, PMID 31221778, PMID 31567024, PMID 34695300

NIH funding

2023 (169), 2018 (118), 2019 (98), 2017 (93), 2025 (92), 2016 (83), 2009 (77), 2014 (75), 2015 (69), 2008 (55), P30CA015083 (50), U10CA180820 (43), 2005 (36), P30CA015704 (34), P30CA033572 (22)